Ikarian Capital’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.95M | Buy |
428,521
+228,425
| +114% | +$1.57M | 0.57% | 31 |
|
|
2025
Q1 | $576K | Hold |
200,096
| – | – | 0.07% | 74 |
|
|
2024
Q4 | $940K | Buy |
200,096
+125,096
| +167% | +$588K | 0.13% | 68 |
|
|
2024
Q3 | $268K | Buy |
+75,000
| New | +$268K | 0.04% | 87 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 85 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 121 |
|
|
2021
Q3 | – | Sell |
-162,700
| Closed | -$1.71M | – | 169 |
|
|
2021
Q2 | $1.71M | Sell |
162,700
-264,039
| -62% | -$2.77M | 0.14% | 93 |
|
|
2021
Q1 | $5.03M | Sell |
426,739
-10,961
| -3% | -$129K | 0.17% | 42 |
|
|
2020
Q4 | $5.13M | Buy |
+437,700
| New | +$5.13M | 0.23% | 35 |
|